Introduction
============

Atrial septal defect (ASD) is a common congenital heart disease with an incidence of 900 per million in the United States \[[@b1-kjtcv-49-421]\], and surgical results of ASD closure are favorable \[[@b2-kjtcv-49-421]\]. Most patients are diagnosed in childhood, but some patients are diagnosed as adults. Seoul National University Hospital has a separate children's hospital, but ASD patients over 15 years old generally visit and undergo surgery at the adult cardiac center.

Median full sternotomy is the standard approach for surgical ASD closure in children and adults. The ASD closure procedure is relatively simple compared to other complex congenital and adult heart diseases, and more people are concerned about cosmetic outcomes. Therefore, minimally invasive cardiac surgery (MICS) for ASD closure has been introduced at many centers.

Our center has used right anterolateral thoracotomy for ASD closure in adult patients for the past 10 years. This study retrospectively reviewed the results of right anterolateral thoracotomy for ASD closure and compared the outcomes with conventional median sternotomy (CMS).

Methods
=======

A total of 125 consecutive patients over 15 years old underwent ASD closure at our institution by a single surgeon from January 2004 to December 2013. Patients who underwent concomitant procedures, such as the Maze procedure, mitral valve annuloplasty, and tricuspid valve annuloplasty, were excluded. Sixty patients with isolated ASD closure constituted the final study population. The age of the patients was between 16 and 73 years. CMS was performed in 42 patients, and MICS was performed in 18 patients. Preoperative, operative, and postoperative data were collected from patients' medical records and compared between the 2 groups. This study was approved by the institutional review board of Seoul National University Hospital (1507-007-683).

In the CMS group, standard median sternotomy was performed, and the usual aortic and bi-caval cannulations were used. Cardioplegia was infused in an antegrade manner via the aortic root cannula, and the ascending aorta was cross-clamped. The right atrium was opened, and the ASD was closed with glutaraldehyde-fixed auto-pericardium.

Patients in the MICS group were positioned with their right side up by inserting towels under the right back. A small incision (approximately 2--3 cm) was made in the inguinal region for femoral artery and vein development. A purse string suture was applied at the common femoral vein, and a venous cannula was inserted and the tip positioned at the inferior vena cava (IVC) level under trans-esophageal echocardiography guidance. Another venous cannula was inserted via the internal jugular vein and positioned at the superior vena cava (SVC) level. Internal jugular vein cannulation was aided by ultrasonography-guided puncture in the operative field. Two venous cannulae were connected with a Y-connector. A purse string suture was applied at the common femoral artery, and an arterial cannula was inserted ([Fig. 1A](#f1-kjtcv-49-421){ref-type="fig"}). A small anterolateral thoracotomy (approximately 6--8 cm) was made at the sub-mammary line, and the pleural cavity was entered through the fourth intercostal space ([Fig. 1B](#f1-kjtcv-49-421){ref-type="fig"}). The pericardium was opened and retracted using a suture that passed through the chest wall via separate incision. The SVC and IVC were snared down with umbilical tape and a slider after cardiopulmonary bypass (CPB) was initiated. Aortic cross-clamp (ACC) was achieved using a Chitwood DeBakey Clamp (Scanlan International Inc., St. Paul, MN, USA) through a separate incision at the second intercostal space. Cardioplegia was infused in an antegrade manner via the aortic root cannula. The right atrium was opened, and the ASD was closed using glutaraldehyde-fixed auto-pericardium. During the entire procedure, CO~2~ gas was infused into the chest wall to reduce the risk of air embolism. No thoracoscopy or thoracoscopic devices were used. The right atrium was closed, the ACC was released, and CPB weaning and decannulation procedures were performed using standard techniques. Thoracotomy and femoral wounds were closed with special concern for cosmetics.

Categorical variables are described using frequency and percentage. Continuous variables are described as the means and standard deviation. Comparisons of categorical variables between 2 groups were performed using the chi-square or the Fisher exact test. Comparisons of continuous variables were performed using the Student t-test or Mann-Whitney U-test after pretests for normal distribution. Statistical significance was accepted when the p-value was \<0.05.

Results
=======

The MICS group was younger (44.6±13.8 years vs. 32.4±11.3 years, p=0.002) and included more females (28 \[66.7%\] vs. 17 \[94.4%\], p=0.025) than the CMS croup. However, preoperative ejection fraction and underlying diseases were not significantly different between the 2 groups ([Table 1](#t1-kjtcv-49-421){ref-type="table"}).

The operation time (188.4±37.8 minutes vs. 286.7± 30.8 minutes, p\<0.001), CPB time (72.7±21.5 minutes vs. 125.8±17.8 minutes, p\<0.001), and ACC time (25.5±9.8 minutes vs. 45.6±9.4 minutes, p\<0.001) were significantly longer in the MICS group. The rectal temperature (32.0°C±1.6°C vs. 27.8°C±1.8°C, p\<0.001) and nasopharyngeal temperature (30.0°C±2.1°C vs. 25.4°C±2.0°C, p\<0.001) were significantly lower in the MICS group. There were no significant differences in intraoperative transfusion ([Table 2](#t2-kjtcv-49-421){ref-type="table"}).

There were no significant differences in morbidities and mortalities between groups. Mechanical ventilation time (14.6±12.2 hours vs. 12.2±7.1 hours, p=0.566), intensive care unit length of stay (LOS) (37.5±37.1 hours vs. 27.4±11.7 hours, p=0.675), and hospital LOS (7.3±10.9 days vs. 5.9±1.9 days, p=0.746) were shorter in the MICS group, but these differences were not statistically significant. Postoperative transfusion was also not significantly different. Only chest tube drainage in the first 24 hours (627.1±742.6 mL vs. 306.1±354.2 mL, p\<0.001) was significantly different. There were no residual shunts or early or late re-interventions in the 2 groups ([Table 3](#t3-kjtcv-49-421){ref-type="table"}).

Discussion
==========

Several methods of MICS for ASD closure have been reported, including partial sternotomy, right parasternal mini-incision, right anterolateral thoracotomy, right posterolateral thoracotomy, video-assisted mini-thoracotomy, robot-assisted surgery, and total thoracoscopic surgery without robotic assistance \[[@b3-kjtcv-49-421]--[@b11-kjtcv-49-421]\]. MICS exhibits a cosmetic advantage. However, MICS has the disadvantages of a restricted operative field and technical difficulties in peripheral cannulation and aortic cross-clamping. Therefore, MICS should exhibit similar outcomes as conventional median sternotomy. Several studies of MICS for ASD closure have been performed, and most results have revealed comparable outcomes between the 2 groups \[[@b12-kjtcv-49-421]--[@b15-kjtcv-49-421]\].

Right anterolateral thoracotomy has the advantage of providing a direct field of vision to the right atrium, which may be incised and approached for ASD. Therefore, the skin incision is minimized and adjusted to the size required for ASD closure. The incision may be entirely hidden in the innerwear line.

Our results revealed that the MICS group experienced significantly longer operation times, CPB times, and ACC times, primarily because femoral vessel development and peripheral cannulation are time-consuming procedures. The restricted operative field also results in longer CPB and ACC times. Therefore, we used lower target body temperatures in the MICS group for major organ protection during the longer procedure. There were no significant differences in postoperative morbidities and mortalities. Re-intervention due to residual defects is an important issue, but there were no residual defects or re-interventions in either group. Because ASD closure embraces a very low level of overall risk, we think that the absence of a marked difference paradoxically reflects the stable implementation of ASD closure using MICS.

There was no conversion to full sternotomy in the MICS group, which means there was no failure of the minimally invasive procedure. There were also no femoral cannulation site complications, such as lymphocele, wound infection, or pseudoaneurysm, in the MICS group. These results suggest that there were no additional complications following the peripheral cannulation procedure.

There was one case of hospital mortality in the CMS group. A 64-year-old woman with chronic renal failure underwent ASD closure and intraoperative hemodialysis catheter insertion via the femoral vein. Vascular injury and intra-abdominal bleeding occurred during catheter insertion. Hematoma evacuation and bleeding control were performed on postoperative day 5. However, ischemic colitis occurred, and the patient died after a long duration of conservative management.

Preoperative characteristics revealed that the MICS group was younger and included more female patients than the CMS group, which reflects the fact that young females are more concerned about cosmetics. They especially dislike median sternotomy, which creates scars that are easily visible in the neckline. Naturally, MICS was performed to satisfy the demand for smaller invisible incision. Finally, patients in the MICS group were satisfied with their small incision and favorable postoperative outcomes.

The limitations of this study are its retrospective nature and small population. To overcome selection bias, propensity score matching was applied. But the matching left only 11 patients in each group, therefore further comparison could not be made. Because we do not bring patients with excellent outcomes back for follow-up in our outpatient clinic several years after surgery, we cannot collect data on cosmetic satisfaction from all patients. Therefore, objective and subjective parameters, such as a visual analogue pain scale, a satisfaction questionnaire, or an exercise test, are absent in this study. Finally, data related to ASD severity, such as Qp/Qs, pulmonary artery systolic pressure, and ASD size, were not compared between groups, because cardiac catheterization was not performed in every patient, and ASD size was not measured in every patient.

In conclusion, MICS via right anterolateral thoracotomy is an alternative choice for ASD closure. The results demonstrated similar morbidity and mortality between groups, and favored MICS in chest tube drainage in the first 24 hours.
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###### 

Preoperative patient characteristics

  Characteristic                          Conventional median sternotomy (n=42)   Minimally invasive cardiac surgery (n=18)   p-value
  --------------------------------------- --------------------------------------- ------------------------------------------- ---------
  Sex (female)                            28 (66.7)                               17 (94.4)                                   0.025
  Age (yr)                                44.6±13.8                               32.4±11.3                                   0.002
  Body mass index (kg/m^2^)               21.9±2.5                                21.7±3.1                                    0.787
  Ejection fraction (%)                   58.4±6.8                                60.1±5.4                                    0.309
  Hypertension                            8 (19.0)                                1 (5.6)                                     0.255
  Diabetes mellitus                       1 (2.4)                                 0                                           \>0.99
  Coronary artery disease                 0                                       0                                           
  Chronic obstructive pulmonary disease   1 (2.4)                                 0                                           \>0.99
  Congestive heart failure                0                                       0                                           
  Transient ischemic attack               0                                       0                                           
  Stroke                                  0                                       0                                           
  Peripheral vascular disease             0                                       0                                           
  Renal failure                           2 (4.8)                                 0                                           \>0.99
  Arrhythmia                              1 (2.4)                                 0                                           \>0.99

Values are presented as number (%) or mean±standard deviation.

###### 

Operative details

  Variable                                       Conventional median sternotomy (n=42)   Minimally invasive cardiac surgery (n=18)   p-value
  ---------------------------------------------- --------------------------------------- ------------------------------------------- ---------
  Operation time (min)                           188.4±37.8                              286.7±30.8                                  \<0.001
  Cardiopulmonary bypass time (min)              72.7±21.5                               125.8±17.8                                  \<0.001
  Aortic cross-clamp time time (min)             25.5±9.8                                45.6±9.4                                    \<0.001
  Lowest rectal temperature (°C)                 32.0±1.6                                27.8±1.8                                    \<0.001
  Lowest nasopharyngeal temperature (°C)         30.0±2.1                                25.4±2.0                                    \<0.001
  Intraoperative transfusion                     9 (21.4)                                1 (5.6)                                     0.256
  Intraoperatively infused blood products (mL)   128.6±312.4                             13.9±59.0                                   0.114

Values are presented as mean±standard deviation or number (%).

###### 

Postoperative results

  Variable                                            Conventional median sternotomy (n=42)   Minimally invasive cardiac surgery (n=18)   p-value
  --------------------------------------------------- --------------------------------------- ------------------------------------------- ---------
  Conversion to sternotomy                                                                    0                                           
  In-hospital mortality                               1 (2.4)                                 0                                           \>0.99
  Reoperation for bleeding                            2 (4.8)                                 0                                           \>0.99
  Cardiac arrest                                      0                                       0                                           
  Neurological complication                           0                                       0                                           
  Respiratory failure                                 0                                       0                                           
  Postoperative intra-aortic balloon pump insertion   0                                       0                                           
  Myocardial infarction                               0                                       0                                           
  Atrial fibrillation                                 8 (19.0)                                1 (5.6)                                     0.255
  Renal failure                                       1 (2.4)                                 0                                           \>0.99
  Wound complication                                  1 (2.4)                                 0                                           \>0.99
  Complication of femoral cannulation                                                         0                                           
  Mechanical ventilation time (hr)                    14.6±12.2                               12.2±7.1                                    0.566
  Intensive care unit LOS (hr)                        37.5±37.1                               27.4±11.7                                   0.675
  Hospital LOS (day)                                  7.3±10.9                                5.9±1.9                                     0.746
  Chest tube drainage in first 24 hours (mL)          627.1±742.6                             306.1±354.2                                 \<0.001
  Blood product requirement                           8 (19.0)                                4 (22.2)                                    0.740
  Postoperatively infused red blood cell (mL)         196.4±598.6                             83.3±257.2                                  0.471
  Postoperatively infused total blood products (mL)   367.9±1,226.5                           183.9±559.6                                 0.889
  Residual defect                                     0                                       0                                           
  Early re-intervention                               0                                       0                                           
  Late re-intervention                                0                                       0                                           

Values are presented as number (%) or mean±standard deviation.

LOS, length of stay.
